Dr. Wang assumes the Directorship of the Center for Policy, Outcomes and Prevention on July 1st, 2014, after having served as its co-Director. Dr. Wang, an Associate Professor of Pediatrics at Stanford University, received his B.S. from MIT, M.D. from Harvard Medical School, and Ph.D. in policy analysis from RAND. After completing his pediatric residency training at UCSF, he worked in Greater China with McKinsey and Company, during which time he performed multiple studies in the Asia healthcare market. In 2000, he was recruited to serve as the project manager for the Taskforce on Reforming Taiwan’s National Health Insurance System. His fellowship training in health services research included the Robert Wood Johnson Clinical Scholars Program and the National Research Service Award Fellowship at UCLA. Much of his research over the past 10 years has focused on improving care and outcomes for preterm infants born very low birth weight (VLBW; <1500g). He has developed quality indicators for follow-up of VLBW infants, assessed quality of care for vision and hearing services, studied the enrollment of VLBW infants in the Early Intervention Program and assessed the needs of VLBW families during the transition from hospital to home. Additionally, he has been involved with many quality improvement (QI) projects, including studying the use of electronic prescribing among clinicians in New Jersey, improving emotional support to patients and increasing the cleanliness of the facilities at UCLA, assessing customer service for a major health plan, optimizing the order-fulfillment process in a computer factory, and integrating management concepts and QI by co-authoring a Harvard Business School case study on breast cancer care with Professor Michael E. Porter. Moreover, he led two QI evaluations across hospital settings, one to improve breast cancer care in an overseas hospital, and another to manage the care of children with Sickle Cell Disease (SCD) at Boston Medical Center. Most recently, he chaired the data working group for the National Initiative for Children’s Healthcare Quality’s (NICHQ) National Coordinating Center for the Sickle Cell Disease Treatment Demonstration Program and the Sickle Cell Disease Newborn Screening Program, to implement quality improvement initiatives and measure quality of care in multiple networks over 13 states to improve outcomes.
Dr. Wang’s current research interests include: 1) developing tools for assessing and improving the value of healthcare; 2) studying competency-based medical education curriculum, 3) facilitating the use of mobile technology in improving quality of care, and 4) engaging in healthcare reform.
Currently, he is funded by the NIH Director’s New Innovator Award and the Lucile Packard Foundation for Children’s Health to develop tools for patient engagement and behavioral change via mobile applications, including apps to foster people’s habits for flossing, to improve adherence to medications in post-transplant patients, and to enhance compliance among individuals with asthma. Additionally, his team is building a mobile app that can help healthcare providers, patients, social workers, and insurers track the progress of a patient’s care in real time, which would be most useful for those with complex chronic conditions. He is also the principal investigator on a NIH Fogarty International Center grant to train scholars from developing countries in Asia on research methods and research ethics.
Dr. Wang has received many honors and awards since he completed his academic training. These include the Robert Wood Johnson Physician Faculty Scholars Career Development Award, NIH K23 Career Development Award, CIMIT Young Clinician Research Award for Transformative Innovation in Healthcare Research and the NIH Director’s New Innovator Award. He was named a “Viewpoints” regular contributor for the Journal of the American Medical Association (JAMA), served as an external reviewer for the 2011 IOM Report “Child and Adolescent Health and Health Care Quality: Measuring What Matters.” He has written two bestselling Chinese language popular books published in Taiwan, and co-authored an English book “Analysis of Healthcare Interventions that Change Patient Trajectories.” His essay, “Time is Ripe for Increased U.S.-China Cooperation in Health,” was selected as the first-place American essay in the 2003 A. Doak Barnett Memorial Essay Contest sponsored by the National Committee on United States-China Relations.
For more information, go to: https://med.stanford.edu/profiles/chih-hung-wang.